# Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy

> **NCT06660940** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 460 (estimated)

## Conditions studied

- Diabetic Kidney Disease
- Diabetic Retinopathy

## Interventions

- **DRUG:** Keluoxin Capsules
- **DRUG:** Keluoxin Capsule Simulants
- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT06660940
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 460 (ESTIMATED)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06660940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06660940, "Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06660940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*